Wireless Car Chargers
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 IBS-D Drugs 1.2.3 IBS-C Drugs 1.2.4 Others 1.3 Market by Application 1.3.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Women 1.3.3 Men 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Perspective (2017-2028) 2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Growth Trends by Region 2.2.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Region (2017-2022) 2.2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Region (2023-2028) 2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Dynamics 2.3.1 Rx Irritable Bowel Syndrome (IBS) Drugs Industry Trends 2.3.2 Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers 2.3.3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Challenges 2.3.4 Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Revenue 3.1.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Revenue (2017-2022) 3.1.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Players (2017-2022) 3.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue 3.4 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio 3.4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2021 3.5 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players Head office and Area Served 3.6 Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service 3.7 Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Type 4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Type (2017-2022) 4.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2023-2028) 5 Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Application 5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Application (2017-2022) 5.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2017-2028) 6.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) 6.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2017-2028) 7.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) 7.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2017-2028) 8.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) 8.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2017-2028) 9.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) 9.3 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2017-2028) 10.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) 10.3 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Ironwood Pharmaceuticals 11.1.1 Ironwood Pharmaceuticals Company Detail 11.1.2 Ironwood Pharmaceuticals Business Overview 11.1.3 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction 11.1.4 Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) 11.1.5 Ironwood Pharmaceuticals Recent Development 11.2 Bausch Health 11.2.1 Bausch Health Company Detail 11.2.2 Bausch Health Business Overview 11.2.3 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Introduction 11.2.4 Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) 11.2.5 Bausch Health Recent Development 11.3 Takeda 11.3.1 Takeda Company Detail 11.3.2 Takeda Business Overview 11.3.3 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Introduction 11.3.4 Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) 11.3.5 Takeda Recent Development 11.4 Sebela Pharmaceuticals 11.4.1 Sebela Pharmaceuticals Company Detail 11.4.2 Sebela Pharmaceuticals Business Overview 11.4.3 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction 11.4.4 Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) 11.4.5 Sebela Pharmaceuticals Recent Development 11.5 Allergan 11.5.1 Allergan Company Detail 11.5.2 Allergan Business Overview 11.5.3 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Introduction 11.5.4 Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) 11.5.5 Allergan Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of IBS-D Drugs Table 3. Key Players of IBS-C Drugs Table 4. Key Players of Others Table 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2017-2022) Table 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2023-2028) Table 11. Rx Irritable Bowel Syndrome (IBS) Drugs Market Trends Table 12. Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers Table 13. Rx Irritable Bowel Syndrome (IBS) Drugs Market Challenges Table 14. Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints Table 15. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players (2017-2022) Table 17. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2021) Table 18. Ranking of Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service Table 22. Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2017-2022) Table 26. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2023-2028) Table 28. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2017-2022) Table 30. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2023-2028) Table 32. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028) & (US$ Million) Table 42. Ironwood Pharmaceuticals Company Detail Table 43. Ironwood Pharmaceuticals Business Overview Table 44. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product Table 45. Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) & (US$ Million) Table 46. Ironwood Pharmaceuticals Recent Development Table 47. Bausch Health Company Detail Table 48. Bausch Health Business Overview Table 49. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Product Table 50. Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) & (US$ Million) Table 51. Bausch Health Recent Development Table 52. Takeda Company Detail Table 53. Takeda Business Overview Table 54. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Product Table 55. Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) & (US$ Million) Table 56. Takeda Recent Development Table 57. Sebela Pharmaceuticals Company Detail Table 58. Sebela Pharmaceuticals Business Overview Table 59. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product Table 60. Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) & (US$ Million) Table 61. Sebela Pharmaceuticals Recent Development Table 62. Allergan Company Detail Table 63. Allergan Business Overview Table 64. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Product Table 65. Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) & (US$ Million) Table 66. Allergan Recent Development Table 67. Research Programs/Design for This Report Table 68. Key Data Information from Secondary Sources Table 69. Key Data Information from Primary Sources List of Figures Figure 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type: 2021 VS 2028 Figure 2. IBS-D Drugs Features Figure 3. IBS-C Drugs Features Figure 4. Others Features Figure 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application in 2021 & 2028 Figure 6. Women Case Studies Figure 7. Men Case Studies Figure 8. Rx Irritable Bowel Syndrome (IBS) Drugs Report Years Considered Figure 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region: 2021 VS 2028 Figure 12. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players in 2021 Figure 13. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2021 Figure 15. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2017-2028) Figure 17. United States Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2017-2028) Figure 21. Germany Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2017-2028) Figure 29. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2017-2028) Figure 37. Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2017-2028) Figure 41. Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Ironwood Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) Figure 44. Bausch Health Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) Figure 45. Takeda Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) Figure 46. Sebela Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) Figure 47. Allergan Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation Figure 50. Key Executives Interviewed
Ironwood Pharmaceuticals Bausch Health Takeda Sebela Pharmaceuticals Allergan
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
B2C Platform For Travel Agencies market is segmented by players, region (country), by Type and by ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More